This online on-demand seminar gives a comprehensive understanding of the reimbursement landscape in-vitro diagnostic tests in China. Provided in the form of the presentation in Acrobat PDF
China is a very complex market with mostly regional market access activities.
At the national level, only scope of services is determined. The scope of services and detailed benefit catalogs are established at the level of local administrative units (provinces and cities).
In out-patient settings, a fee for service model is used for reimbursement of services and in-vitro diagnostic tests.
We offer a seminar on critical elements of the reimbursement system for IVD tests in China, that can guide your decision-making about the introduction of novel technologies into this market.
Key stakeholders are reviewed, including payers, policy-makers, decision influencers, advising organizations (health technology assessment) and support bodies
Money flow and distribution of funds, different types of insurances, overall approach to market access in China
The role of national and local documents, structure of the catalogs, process to include a novel IVD test to the regional catalogs
Role of health technology assessment in market access, reforms towards unifying the coverage
Some topics are not specifically covered in this seminar: reimbursement of hospital procedures and medical devices, reimbursement for medical aids (devices for home use), funding of capital equipment.
The introductory presentation also does not include all the details of reimbursement application processes.
Topics that are not covered in this seminar will be included in future courses. You can subscribe to our newsletter and inform us about your particular interests at the main page of the Market Access Academy.
At the moment, you can only access the educational material as the full presentation of the seminar in Acrobat PDF